{"company":{"id":9512,"name":"Logomix","domain":"logomix.bio","url":"https://alion.io/company/logomix"},"answer":"As of Nov 17, 2026, Alion lists 10 companies most like Logomix: Dyno Therapeutics, NewLimit, HarborSite, Spearhead Bio, Exthymic, Genscript, Cellcolabs, eGenesis, ProKidney and 2026 Kamau Therapeutics, Inc..","highlights":["Logomix itself has 8 open roles on Alion.","Of them, Genscript is hiring the most, with 70 open roles.","eGenesis has raised the most venture funding on record: $239.6M.","Open roles at Genscript rose the most: from 58 on Oct 19, 2026 to 70 now."],"as_of":"2026-11-17","cite":"Alion, \"Logomix competitors and alternatives: 10 similar companies compared on hiring and funding\", as of Nov 17, 2026. https://alion.io/company/logomix/competitors","indexable":true,"target":{"name":"Logomix","url":"https://alion.io/company/logomix","domain":"logomix.bio","open_roles":8,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":null,"headquarters":{"city":"Yokohama","country":"JP"},"technologies":["Single-Cell Sequencing","Machine Learning","Next-Generation Sequencing"],"hiring_countries":["JP"],"similarity":null},"competitors":[{"name":"Dyno Therapeutics","url":"https://alion.io/company/dyno-therapeutics","domain":"dynotx.com","open_roles":1,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Watertown","country":"US"},"technologies":["Machine Learning","CUDA","AI Agents"],"hiring_countries":["US"],"similarity":{"score":12.02,"shared_segments":["Synthetic Biology","Cell & Gene Therapy"],"shared_technologies":["AWS","Machine Learning","Cell Culture","Next-Generation Sequencing"],"same_hq_country":false}},{"name":"NewLimit","url":"https://alion.io/company/newlimit","domain":"newlimit.com","open_roles":15,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"San Francisco","country":"US"},"technologies":["Machine Learning","Python","LLM"],"hiring_countries":["US"],"similarity":{"score":11.72,"shared_segments":["Regenerative Medicine","Cell & Gene Therapy"],"shared_technologies":["AWS","LLM","Machine Learning","CRISPR","Cell Culture"],"same_hq_country":false}},{"name":"HarborSite","url":"https://alion.io/company/harborsite","domain":"harborsite.com","open_roles":0,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"11-50","headquarters":null,"technologies":[],"hiring_countries":[],"similarity":{"score":10,"shared_segments":["Synthetic Biology","Cell & Gene Therapy"],"shared_technologies":[],"same_hq_country":false}},{"name":"Spearhead Bio","url":"https://alion.io/company/spearhead-bio","domain":"spearheadbio.com","open_roles":0,"open_roles_change":null,"funding":{"total_raised_usd":6225000,"last_round":"convertible_note","last_round_usd":1200000,"last_round_date":"2026-06-18","lead_investors":[]},"size_band":"11-50","headquarters":{"city":"Saint Louis","country":"US"},"technologies":[],"hiring_countries":[],"similarity":{"score":10,"shared_segments":["Synthetic Biology","Cell & Gene Therapy"],"shared_technologies":[],"same_hq_country":false}},{"name":"Exthymic","url":"https://alion.io/company/exthymic","domain":"exthymic.com","open_roles":4,"open_roles_change":null,"funding":{"total_raised_usd":10249992,"last_round":"venture","last_round_usd":10249992,"last_round_date":"2024-04-30","lead_investors":[]},"size_band":"11-50","headquarters":{"city":"San Diego","country":"US"},"technologies":["GMP","Python","Design History File"],"hiring_countries":["US"],"similarity":{"score":9.82,"shared_segments":["Cell & Gene Therapy","Regenerative Medicine"],"shared_technologies":["Cell Culture"],"same_hq_country":false}},{"name":"Genscript","url":"https://alion.io/company/genscript","domain":"genscript.com","open_roles":70,"open_roles_change":{"since":"2026-10-19","from":58,"to":70,"pct":21},"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"1001-5000","headquarters":{"city":"Piscataway","country":"US"},"technologies":["Python","HPLC","Western Blot"],"hiring_countries":["US","SG","KR"],"similarity":{"score":9.45,"shared_segments":["Synthetic Biology","Cell & Gene Therapy"],"shared_technologies":["CRISPR","Cell Culture","Next-Generation Sequencing"],"same_hq_country":false}},{"name":"Cellcolabs","url":"https://alion.io/company/cellcolabs","domain":"cellcolabs.com","open_roles":1,"open_roles_change":null,"funding":{"total_raised_usd":8700000,"last_round":"venture","last_round_usd":8700000,"last_round_date":"2024-03-05","lead_investors":[]},"size_band":"11-50","headquarters":{"city":"Solna","country":"SE"},"technologies":[],"hiring_countries":["TH"],"similarity":{"score":9.42,"shared_segments":["Regenerative Medicine","Cell & Gene Therapy"],"shared_technologies":[],"same_hq_country":false}},{"name":"eGenesis","url":"https://alion.io/company/egenesis","domain":"egenesis.com","open_roles":9,"open_roles_change":null,"funding":{"total_raised_usd":239618354,"last_round":"venture","last_round_usd":124999955,"last_round_date":"2021-02-26","lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Cambridge","country":"US"},"technologies":["GCP","GMP","Flow Cytometry"],"hiring_countries":["US"],"similarity":{"score":9.32,"shared_segments":["Cell & Gene Therapy","Regenerative Medicine"],"shared_technologies":["Cell Culture"],"same_hq_country":false}},{"name":"ProKidney","url":"https://alion.io/company/prokidney","domain":"prokidney.com","open_roles":5,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Winston-Salem","country":"US"},"technologies":["GMP","SAS","CAPA"],"hiring_countries":["US"],"similarity":{"score":9.32,"shared_segments":["Regenerative Medicine","Cell & Gene Therapy"],"shared_technologies":["Cell Culture"],"same_hq_country":false}},{"name":"2026 Kamau Therapeutics, Inc.","url":"https://alion.io/company/kamautx","domain":"kamautx.com","open_roles":0,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":null,"technologies":[],"hiring_countries":[],"similarity":{"score":9.17,"shared_segments":["Cell & Gene Therapy","Regenerative Medicine"],"shared_technologies":[],"same_hq_country":false}}],"method":"Ranked by Alion's similar-companies engine (the MCP tool similar_companies): shared industry segments and the overlap of the two segment sets, technologies named in both companies' job postings, the same headquarters country, a size band near it. Open roles are the visible postings on Alion today; their change is shown only for boards that state posting dates.","html_url":"https://alion.io/company/logomix/competitors","json_url":"https://alion.io/company/logomix/competitors.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","built_at":"2026-11-17T02:50:30Z","generated_at":"2026-11-18T05:23:08Z"}}